Como el artculo data de 1984 y no aparece incluso ni el abstract en Pubmed, no he podido acceder al full text
Furthermore, limited target specificity has been cited as a barrier to its use as a lead compound in drug discovery (El-Saadony et al., 2025)
[2] Nonalcoholic Fatty Liver Disease | Johns Hopkins Medicine. Accessed: Nov
By reducing weight, even modest amountspeople in the semaglutide arm lost about 9% of their body weight over two years in this studywe are reducing the filtering load on the kidneys
Goebel KM, Storck U, Neurath F
In health, GLP-1 stimulates the synthesis and secretion of insulin from pancreatic -cells in a glucose-dependent manner (i.e., it is activated when blood glucose levels are elevated, typically in the postprandial state)